Multiple logistic regression analysis revealed that both serum lipocalin-2 and RBP4 were independent risk factors for subclinical atherosclerosis in type 2 diabetes, and the impact of lipocalin-2 or RBP4 on atherosclerosis was independent of age, sex, BMI, and other classical cardiovascular risk factors. Here, LCN2 is linked to type 2 diabetes mellitus.